Tumour vaccines: Personal training by vaccination
Nature Reviews Immunology 17, 468 (2017).
doi:10.1038/nri.2017.88
Author: Ulrike Harjes
Two groups have shown that personalized, neoantigen-based tumour vaccines elicit effective T cell responses in patients with advanced melanoma, leading to favourable clinical outcomes. Combination with checkpoint blockade can be of additional benefit.
Source: Nature Reviews Immunology - Category: Allergy & Immunology Authors: Ulrike Harjes Tags: Research Highlight Source Type: research
More News: Allergy & Immunology | Melanoma | Skin Cancer | Training | Universities & Medical Training | Vaccines